4 unchanged sentences
333-254534) that was declared effective on April 8, 2021 and registered an aggregate of 7,187,500 shares of our common stock.
−Removed: On April 13, 2021, we completed our IPO and sold 6,250,000 shares of our common stock at a public offering price of $15.00 per share for aggregate gross proceeds of $93.8 million before deducting underwriters’ discounts and commissions and offering-related expenses.
+Added: On April 13, 2021, we completed our IPO and sold 6,250,000 shares of our common stock at a public offering price of $15.00 per share for aggregate gross proceeds of $93.8 million before deducting underwriters’
+Added: discounts and commissions and offering-related expenses.
Net proceeds, after deducting underwriting discounts and commissions of $6.6 million and offering expenses of approximately $2.6 million, were $84.6 million.
1 unchanged sentence
acted as joint book-running managers.
−Removed: As of March 31, 2022 , we have not used any of the proceeds from our IPO.
+Added: As of June 30, 2022, we have not used any of the proceeds from our IPO.
We invested the funds received in highly liquid money market funds and short-term investments.
−Removed: The net proceeds from the IPO will be used, together with our cash, cash equivalents, and short-term investments to fund continued research and development of REN0001 in patients with PM M and LC-FAOD , other clinical trials and preclinical studies, and commercial readiness preparations, and to provide funds for working capital and other general purposes.
−Removed: the offering proceeds were paid directly or indirectly to any of our directors or officers (or their associates) or persons owning 10.0% or more of any class of our equity securities or to any other affiliates.
+Added: The net proceeds from the IPO will be used, together with our cash, cash equivalents, and short-term investments to fund continued research and development of REN0001 in patients with PMM and LC-FAOD, other clinical trials and preclinical studies, and commercial readiness preparations, and to provide funds for working capital and other general purposes.
+Added: None of the offering proceeds were paid directly or indirectly to any of our directors or officers (or their associates) or persons owning 10.0% or more of any class of our equity securities or to any other affiliates.
Defaults Upon Senior Securities
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.